Archives
-
L1023 Anti-Cancer Compound Library Workflow
2026-09-09
Build pathway-aware cancer screens with a pre-dissolved compound collection spanning kinase, proteostasis, epigenetic, and apoptosis targets. Pair L1023 phenotypic screening with STING mechanism-informed follow-up to distinguish pathway modulation from nonspecific cytotoxicity.
-
MCL-1 Dependence in Breast Cancer and Apoptosis
2026-09-08
The reference study shows that MCL-1 supports established breast tumors primarily through its canonical anti-apoptotic function, rather than through an independent non-apoptotic activity. By combining genetic deletion, pharmacological inhibition, tumor models, and BAX/BAK dependency analysis, the authors connect MCL-1 targeting to mitochondrial apoptosis and identify implications for breast cancer and stem-cell research.
-
Gastrodin, AT1 Signaling, and Astrocyte Reactivity
2026-09-08
The reference study shows that activated microglia can reshape astrocyte renin–angiotensin system and inflammatory responses through an AT1-linked RAS–SIRT3 pathway. Its conditioned-medium model and azilsartan perturbation experiments provide a useful framework for separating microglia-to-astrocyte signaling from direct drug effects.
-
Cytochalasin B Workflows for Actin Assays
2026-09-07
Build more interpretable actin assays with Cytochalasin B, a reversible perturbation tool for migration, uptake, cytokinesis, and cytoskeletal drug discovery. This guide combines dose-finding, orthogonal toxicity checks, and troubleshooting with lessons from a modern genotoxicity testing workflow.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-09-07
Song et al. show that murine norovirus exploits NINJ1-mediated plasma membrane rupture to release the viral protein NS1 while simultaneously promoting broad cellular DAMP release. Combining CRISPR screening, cell biology, mutagenesis, and mouse infection models, the study identifies a caspase-3– and NINJ1-dependent unconventional secretion pathway with implications for host–virus interaction research.
-
DiscoveryProbe FDA-approved Drug Library in Context
2026-09-05
A state-aware screening workflow turns a clinically annotated compound collection into a sharper tool for drug repositioning and cancer research drug screening. The approach pairs broad phenotypic coverage with time-resolved controls that help distinguish genuine resistance biology from culture-induced assay variation.
-
Bestatin-Derived Inhibitors of IRAP and ERAP1
2026-09-04
The reference study develops a stereoselective route for functionalizing Bestatin’s α-hydroxy-β-amino acid scaffold and applies structural biology to improve inhibitor potency and selectivity. Its most important result is a cell-active, low-nanomolar IRAP inhibitor with more than 120-fold selectivity over homologous aminopeptidases, while X-ray structures identify GAMEN-loop interactions as an underappreciated determinant of recognition.
-
15-PGDH Inhibition Supports Muscle Recovery
2026-09-04
A 2026 PNAS study shows that inhibiting 15-PGDH can improve muscle stem cell activity, regenerated myofiber growth, and force recovery during semaglutide-associated weight loss in obese mice. The work suggests that combining a 15-PGDH inhibitor with a GLP-1 receptor agonist may preserve regenerative muscle quality without weakening weight-loss efficacy.
-
U0126-EtOH: Translational MEK/ERK Strategy
2026-09-03
U0126-EtOH is a selective MEK1/2 inhibitor for testing causal MAPK/ERK signaling in neuronal, inflammatory, and cancer research. This thought-leadership guide connects mechanism, protocol design, model selection, and translational decision-making beyond a conventional product overview.
-
Tacalcitol Monohydrate: Applied Research Workflows
2026-09-03
Tacalcitol monohydrate connects VDR-driven keratinocyte biology with practical NGF and colorectal cancer assays. This guide translates published concentrations, timing, formulation, and troubleshooting considerations into reproducible workflows for dermatology and oncology research.
-
Stem Cell Screens That Measure Biology, Not Just Death
2026-09-02
High-content screening becomes more translational when it quantifies cell-state mechanisms rather than relying on viability alone. A 280-compound parasite stem-cell study illustrates how DiscoveryProbe™ Stem Cell Compound Library Plus can connect pathway coverage, phenotypic imaging, and orthogonal validation while clarifying the limits of cross-domain evidence.
-
(+)-Bicuculline: Practical Workflow Guide
2026-09-02
(+)-Bicuculline is a research-use GABAA receptor antagonist for controlled studies of inhibitory neurotransmission, synaptic NMDA receptor signaling modulation, and related neuronal endpoints. This guide focuses on solvent selection, stock preparation, storage, controls, and interpretation; the compound is not intended for diagnostic, therapeutic, or clinical use.
-
MTT Assays: Reading Metabolism, Not Just Viability
2026-09-01
Discover how MTT converts intracellular redox activity into a practical readout for proliferation and cytotoxicity studies. This article shows how to interpret MTT results more rigorously in redox-active nanomedicine and glioblastoma research.
-
7-Ethyl-10-hydroxycamptothecin in Cell Assays
2026-09-01
A scenario-based guide to using 7-Ethyl-10-hydroxycamptothecin (SN-38, SKU N2133) in viability, proliferation, cytotoxicity, apoptosis, and cell-cycle studies. It connects mechanism, solvent compatibility, assay design, interpretation, and practical supplier selection to improve experimental consistency.
-
Coumestrol, PMAIP1, and Ferroptosis in RA-FLS
2026-08-31
The reference study identifies a mechanistic link between Coumestrol, TRIM3-dependent protein turnover, mitochondrial PMAIP1 stability, and ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes. Its findings suggest that redirecting the survival state of RA-FLS may suppress both pathological proliferation and inflammatory cytokine production, while also highlighting important limits for translation beyond the cell model.